Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26576

1.

Dermatomyositis Associated with Lung Neuroendocrine Carcinoma.

Takashima R, Takamatsu K, Shinkawa Y, Yagita M, Fukui M, Fujita M.

Intern Med. 2017;56(6):719-724. doi: 10.2169/internalmedicine.56.7768.

PMID:
28321077
2.

Widespread poikilodermatous dermatomyositis associated with chronic lymphocytic leukemia.

Ventarola DJ, Contard PC, Phelps RG.

Cutis. 2017 Feb;99(2):E9-E10. No abstract available.

PMID:
28319632
3.

Ataxia-telangiectasia: recommendations for multidisciplinary treatment.

van Os NJ, Haaxma CA, van der Flier M, Merkus PJ, van Deuren M, de Groot IJ, Loeffen J, van de Warrenburg BP, Willemsen MA; A-T Study Group..

Dev Med Child Neurol. 2017 Mar 20. doi: 10.1111/dmcn.13424. [Epub ahead of print] Review.

PMID:
28318010
4.

Case series of pulsed dye laser treatment of telangiectasia in 23 patients with systemic sclerosis.

Burillo-Martinez S, Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, López-Gómez S, Maroñas-Jimenez L.

Int J Dermatol. 2017 Mar 20. doi: 10.1111/ijd.13595. [Epub ahead of print] No abstract available.

PMID:
28317090
5.

A Marked Response to Immunosuppressive Intervention for Abruptly Occurring Cardiac Complications in a Case of Juvenile Systemic Sclerosis Overlapped with Dermatomyositis.

Nagamori T, Yoshida Y, Takahashi H, Oka H, Kajihama A, Nakau K, Sugimoto M, Minami-Hori M, Azuma H.

Case Rep Pediatr. 2017;2017:1479012. doi: 10.1155/2017/1479012.

6.

Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey.

Chaturvedi S, Clancy M, Schaefer N, Oluwole O, McCrae KR.

Thromb Res. 2017 Mar 9;153:14-18. doi: 10.1016/j.thromres.2017.03.003. [Epub ahead of print]

PMID:
28314138
7.

A chronic recurrent disease course of dermatomyositis is associated with autoantibodies against TIF1γ.

Meisterfeld S, Röber N, Conrad K, Beissert S, Aringer M, Günther C.

Br J Dermatol. 2017 Mar 17. doi: 10.1111/bjd.15468. [Epub ahead of print]

PMID:
28314058
8.

Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine.

Glazer AM, Sofen BD, Rigel DS, Shupack JL.

J Drugs Dermatol. 2017 Mar 1;16(3):280-282.

PMID:
28301625
9.

Periorbital discoid lupus: a rare localization in a patient with systemic lupus erythematosus.

Cakici O, Karadag R, Bayramlar H, Ozkanli S, Uzuncakmak TK, Karadag AS.

An Bras Dermatol. 2016 Sep-Oct;91(5 suppl 1):122-124. doi: 10.1590/abd1806-4841.20164708.

10.

The Use of Rituximab in the Management of Refractory Dermatomyositis.

Kuye IO, Smith GP.

J Drugs Dermatol. 2017 Feb 1;16(2):162-166.

PMID:
28300859
11.

Incidence of typically Severe Primary Immunodeficiency Diseases in Consanguineous and Non-consanguineous Populations.

Broides A, Nahum A, Mandola AB, Rozner L, Pinsk V, Ling G, Yerushalmi B, Levy J, Givon-Lavi N.

J Clin Immunol. 2017 Mar 16. doi: 10.1007/s10875-017-0378-6. [Epub ahead of print]

PMID:
28299599
12.

A study of acute muscle dysfunction with particular reference to dengue myopathy.

Verma R, Holla VV, Kumar V, Jain A, Husain N, Malhotra KP, Garg RK, Malhotra HS, Sharma PK, Kumar N.

Ann Indian Acad Neurol. 2017 Jan-Mar;20(1):13-22. doi: 10.4103/0972-2327.199914.

13.

Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.

Ge Y, Lu X, Shu X, Peng Q, Wang G.

Sci Rep. 2017 Mar 15;7(1):188. doi: 10.1038/s41598-017-00240-6.

14.

Hereditary Hemorrhagic Telangiectasia Management.

Peterson J.

Radiol Technol. 2017 Jan;88(3):277-294.

PMID:
28298578
15.

Mutual interaction between endothelial cells and mural cells enhances BMP9 signaling in endothelial cells.

Tachida Y, Izumi N, Sakurai T, Kobayashi H.

Biol Open. 2017 Mar 15;6(3):370-380. doi: 10.1242/bio.020503.

16.

Epistaxis grading in Osler's disease: comparison of comprehensive scores with detailed bleeding diaries.

Parzefall T, Wolf A, Frei K, Kaider A, Riss D.

Int Forum Allergy Rhinol. 2017 Mar;7(3):293-299. doi: 10.1002/alr.21867.

PMID:
28297555
17.

Fluorescein Angiography Versus Optical Coherence Tomography Angiography in Macular Telangiectasia Type I Treated With Bevacizumab Therapy.

Yannuzzi NA, Gregori NZ, Roisman L, Gupta N, Goldhagen BE, Goldhardt R.

Ophthalmic Surg Lasers Imaging Retina. 2017 Mar 1;48(3):263-266. doi: 10.3928/23258160-20170301-12.

PMID:
28297041
18.

Adult-onset Still's disease with atypical cutaneous manifestations.

Narváez Garcia FJ, Pascual M, López de Recalde M, Juarez P, Morales-Ivorra I, Notario J, Jucglà A, Nolla JM.

Medicine (Baltimore). 2017 Mar;96(11):e6318. doi: 10.1097/MD.0000000000006318.

19.

TP53 and ATM mRNA expression in skin and skeletal muscle after low-level laser exposure.

Guedes de Almeida L, Silva Sergio LP, de Paoli F, Mencalha AL, da Fonseca AS.

J Cosmet Laser Ther. 2017 Feb 16:1-5. doi: 10.1080/14764172.2017.1293829. [Epub ahead of print]

PMID:
28296509
20.

Simvastatin-associated dermatomyositis.

Fania L, Didona D, Tonanzi T, Mazzanti C, Didona B.

Dermatol Ther. 2017 Mar 14. doi: 10.1111/dth.12480. [Epub ahead of print] No abstract available.

PMID:
28296009

Supplemental Content

Loading ...
Support Center